Reduced PTPN12 expression correlates with improved breast cancer patient outcome on Kaplan–Meier analysis (p = 0.00651), supporting a tumor suppressor role for PTPN12 in human breast cancer (Fig. S4i). The gene discussed is PTPN12; the disease is neoplasm.